Enache EL, et al. - This trial entailed the exploration of the efficacy of triplex HRM assay, in chronic hepatitis C (CHC) patients. This assay encompassed a diagnostic test for simultaneous genotyping of IL28B, ABCB11 and RNF7 in CHC patients. Reliable and inexpensive, the assay ought to yield beneficial information regarding the clinical management of CHC, like detection of patients at risk of rapid disease progression or with high chances of response to classical therapy.